---
title: "Spatial Transcriptomics of Murine Colon in Steady State and During Recovery After DSS Colitis"
permalink: /posts/2015-08-14-blog-post-3/
date: 2023-11-02
excerpt: 'Mice Colon DSS Model(GSE169749), Nat Commun 2022 Feb 11;13(1):828. <br/>
<img src="/images/IL18-D0.png"  style="width:600px; height:250px;">'

tags:
  - Bioinformatics
---

Background
======
Reference：The spatial transcriptomic landscape of the healing mouse intestine following damage

Spatial transcriptomics is a cutting-edge technology that enables the comprehensive analysis of gene expression profiles within the context of tissue architecture. This approach provides a high-resolution map of transcriptional activity, allowing researchers to investigate the spatial organization of cell types and their functional states in complex tissues. In the context of inflammatory bowel disease (IBD), the dextran sulfate sodium (DSS)-induced colitis model is widely used to study the pathogenesis and potential therapeutic interventions. This study focuses on the spatial transcriptomic analysis of intestinal tissue at two critical time points: day 0 (D0, baseline) and day 14 (D14, peak inflammation) in the DSS-induced colitis model.

Technical Overview:
Spatial transcriptomics combines high-throughput RNA sequencing with spatial localization, enabling the simultaneous measurement of gene expression and its spatial distribution within tissue sections. The technology typically involves the following steps:

Tissue Preparation: Intestinal tissue samples are collected at D0 and D14, snap-frozen, and sectioned onto specialized slides coated with barcoded oligonucleotides.

mRNA Capture: Tissue sections are permeabilized to release mRNA, which is then captured by the barcoded oligonucleotides on the slide. Each barcode corresponds to a specific spatial location within the tissue.

Library Preparation and Sequencing: The captured mRNA is reverse-transcribed into cDNA, amplified, and sequenced using next-generation sequencing (NGS) platforms.

Data Analysis: Computational tools are employed to map the sequenced reads back to their spatial locations, reconstructing the gene expression profiles across the tissue.

Research Analysis:
The spatial transcriptomic analysis of intestinal tissue in the DSS-induced colitis model at D0 and D14 provides several key insights:

Baseline Gene Expression (D0): At D0, the spatial transcriptomic profile reveals the homeostatic gene expression patterns in the intestinal tissue. Key markers of epithelial cells, immune cells, and stromal cells are uniformly distributed, reflecting the normal architecture and function of the intestine. This baseline data serves as a critical reference for identifying changes induced by DSS treatment.

Inflammatory Response (D14): By D14, the spatial transcriptomic data captures the profound changes associated with DSS-induced colitis. There is a marked upregulation of pro-inflammatory cytokines (e.g., IL-1β, TNF-α) and chemokines (e.g., CCL2, CXCL1) in specific regions of the tissue, particularly in areas with dense immune cell infiltration. The spatial distribution of these inflammatory mediators provides insights into the localized immune response and the interplay between different cell types.

Epithelial Barrier Dysfunction: The analysis reveals significant alterations in the expression of genes involved in epithelial barrier function (e.g., tight junction proteins such as occludin and claudins) at D14. These changes are spatially correlated with regions of epithelial damage and ulceration, highlighting the role of barrier dysfunction in the pathogenesis of colitis.

Stromal Remodeling: Spatial transcriptomics also uncovers the dynamic changes in the stromal compartment, with increased expression of extracellular matrix (ECM) remodeling genes (e.g., MMPs, TIMPs) and fibroblast activation markers (e.g., α-SMA) in areas of tissue injury. This suggests a role for stromal cells in the repair and fibrotic responses during colitis.

Cell-Cell Interactions: The spatial resolution of the data allows for the identification of potential cell-cell interactions. For example, the colocalization of immune cells (e.g., macrophages, T cells) with epithelial cells in regions of active inflammation suggests a role for these interactions in driving the inflammatory response.

Conclusion:
Spatial transcriptomic analysis of the DSS-induced colitis model at D0 and D14 provides a comprehensive view of the spatial and temporal dynamics of gene expression in intestinal tissue. This approach not only enhances our understanding of the molecular mechanisms underlying colitis but also identifies potential therapeutic targets that are spatially restricted within the tissue. The integration of spatial transcriptomics with other omics technologies and functional studies will further advance our knowledge of IBD and inform the development of spatially targeted therapies.

Results
======

**Overview** <br/><img src="/images/DSS_ST_Overview.png"><br/><br/>

**Overview** <br/><img src="/images/DSS_ST_correlationw.png"><br/><br/>

**IL-18 DO** <br/><img src="/images/IL18-D0.png"><br/><br/>

**IL-18 D14** <br/><img src="/images/IL18-D14.png"><br/><br/>

**ILC3 DO** <br/><img src="/images/ILC3-D0.png"><br/><br/>

**ILC3 D14** <br/><img src="/images/ILC3-D14.png"><br/><br/>


Method
======
```cmd
git clone https://github.com/ludvigla/murine_colon_explorer
cd murine_colon_explorer
Rscript install-packages.R
```

```R
setwd("~/murine_colon_explorer")
library(shiny)
runApp()
```
